Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,846 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00191711 | Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. | completed | Phase 2 | 43 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00200187 | A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery | completed | Phase 2 | 246 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 |
| clinicaltrials |
| NCT00040586 | Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 | completed | Phase 2 | — | BZL BiologicsINDUSTRY | 1 | Jan 22, 2007 | clinicaltrials |
| NCT00421265 | Active Surveillance for Prostate Cancer With Indolent Features | unknown | — | 150 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Jan 11, 2007 | clinicaltrials |
| NCT00419627 | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas | unknown | — | 160 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Jan 8, 2007 | clinicaltrials |
| NCT00166985 | The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Dec 27, 2006 | clinicaltrials |
| NCT00154583 | Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions | unknown | — | 500 | National Taiwan University HospitalOTHER | 1 | Dec 21, 2006 | clinicaltrials |
| NCT00072722 | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | completed | Phase 2 | 36 | Celgene CorporationINDUSTRY | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00173394 | The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients | unknown | — | 250 | National Taiwan University HospitalOTHER | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00154479 | The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus | unknown | — | 700 | National Taiwan University HospitalOTHER | 1 | Dec 14, 2006 | clinicaltrials |
| NCT00404326 | Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer | completed | Phase 2 | 18 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 28, 2006 | clinicaltrials |
| NCT00102414 | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer | completed | Phase 3 | 356 | AGO Study GroupOTHER | 0 | Nov 14, 2006 | clinicaltrials |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 30 | Morton Plant Mease Health CareOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00074867 | Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer | completed | Phase 2 | 29 | PfizerINDUSTRY | 2 | Nov 7, 2006 | clinicaltrials |
| NCT00040170 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | terminated | Phase 2 | 50 | TransgeneINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00388687 | Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer | unknown | — | 25 | Medical University of ViennaOTHER | 1 | Oct 17, 2006 | clinicaltrials |
| NCT00163930 | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | unknown | — | — | Bayside HealthOTHER_GOV | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00103545 | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | completed | Phase 1 / Phase 2 | 36 | AGO Study GroupOTHER | 1 | Oct 2, 2006 | clinicaltrials |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer | unknown | Phase 3 | 178 | Association of Urologic Oncology (AUO)OTHER | 1 | Sep 27, 2006 | clinicaltrials |
| NCT00146458 | Usefulness of FDG-PET for Advanced Cervical Cancer | unknown | Phase 3 | 200 | Chang Gung Memorial HospitalOTHER | 1 | Sep 20, 2006 | clinicaltrials |
| NCT00100243 | Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | completed | Phase 2 | 22 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer | terminated | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Sep 15, 2006 | clinicaltrials |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | terminated | Phase 2 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00375687 | Investigation of Early Hormonotherapy Efficacy of Prostate Cancer | unknown | N/A | 61 | Kaunas University of MedicineOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | suspended | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00039793 | Massage Therapy for Cancer-Related Fatigue | completed | Phase 2 | 45 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00070967 | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer | completed | Phase 2 | 40 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00038662 | Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure | completed | Phase 2 | 200 | AbbottINDUSTRY | 2 | Aug 15, 2006 | clinicaltrials |
| NCT00102375 | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer | completed | Phase 3 | 900 | AGO Study GroupOTHER | 1 | Aug 4, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00034593 | A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 3 | Jul 19, 2006 | clinicaltrials |
| NCT00035061 | A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00343356 | Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder | completed | Phase 2 | 138 | LanZhou UniversityOTHER | 0 | Jun 22, 2006 | clinicaltrials |
| NCT00263107 | Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. | completed | — | 270 | University of California, DavisOTHER | 1 | May 31, 2006 | clinicaltrials |
| NCT00275353 | Effectiveness of an Individualized Symptom Education Program (ISEP) | completed | Phase 2 | 144 | University of TorontoOTHER | 1 | May 26, 2006 | clinicaltrials |
| NCT00237562 | Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit | completed | Phase 3 | — | University of California, IrvineOTHER | 1 | May 5, 2006 | clinicaltrials |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma | terminated | Phase 1 / Phase 2 | 60 | Celgene CorporationINDUSTRY | 1 | Apr 12, 2006 | clinicaltrials |
| NCT00312988 | Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | completed | Phase 3 | 450 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Apr 11, 2006 | clinicaltrials |
| NCT00011518 | Bladder Cancer Case Control Study of Arsenic in Water | completed | — | 600 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Mar 23, 2006 | clinicaltrials |
| NCT00188383 | Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy | unknown | Phase 1 / Phase 2 | 132 | University Health Network, TorontoOTHER | 1 | Mar 14, 2006 | clinicaltrials |
| NCT00291369 | Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis | completed | Phase 3 | 456 | Centre Leon BerardOTHER | 1 | Feb 16, 2006 | clinicaltrials |
| NCT00103428 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 69 | Cell GenesysINDUSTRY | 1 | Feb 2, 2006 | clinicaltrials |
| NCT00199680 | Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer | unknown | Phase 2 | 42 | University Hospital, LimogesOTHER | 1 | Feb 1, 2006 | clinicaltrials |
| NCT00228124 | PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition | unknown | — | 300 | Ontario Cancer Research NetworkNETWORK | 1 | Jan 26, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Jan 26, 2007source: clinicaltrials